Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ángel Luis Guerrero
OnabotulinumtoxinA Treatment for Chronic Migraine: Experience in 52 Patients Treated With the PREEMPT Paradigm
SpringerPlus
Multidisciplinary
Related publications
P010. OnabotulinumtoxinA for Treatment of Chronic Migraine: Results After 1 Year of Treatment
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
Prediction of Patient's Response to OnabotulinumtoxinA Treatment for Migraine
Heliyon
Multidisciplinary
P025. Two-Year Follow-Up With OnabotulinumtoxinA for Chronic Migraine: A Real Life Evaluation of 113 Patients
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
Real-World Effectiveness of onabotulinumtoxinA Treatment for the Prevention of Headaches in Adults With Chronic Migraine in Australia: A Retrospective Study
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
074 Early Australian Experience With Erenumab for Chronic Migraine
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
O051. Chronic Migraine and onabotulinumtoxinA: A Prospective Study on Patients Treated at the Headache Centre of the Padua University and Analysis of Possible Predictors of Responsivity
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
Guidelines on Prophylactic Treatment With Botulinum Tox-In Type a in Patients With Chronic Migraine
Lijecnicki Vjesnik
Medicine
Long-Term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache Over 3 Years of Therapy
Frontiers in Neurology
Neurology
Multidisciplinary Approach to Patients With Chronic Migraine and Medication Overuse: Experience at the Besta Headache Center
Neurological Sciences
Dermatology
Medicine
Psychiatry
Neurology
Mental Health